Hellenic BioCluster (HBio), the first and largest Health and Biotechnology Cluster in Greece, has received funding from the General Secretariat for Research and Technology to Accelerate Growth by Linking Health Innovation to Market.
For the past 14 years, HBio has been connecting industry and academia partners aiming to support innovative and impact science. HBio has created a strong ecosystem including major research institutes within Greece (FORTH, CERTH, BRFAA, BSRC Alexander Fleming, NCSR Demokritos) and Universities, major partners from the pharmaceutical sector, SMEs, startups and spinoffs from across the health and biotechnology sector and has become a strong innovation process moderator and facilitator in Greece. HBio continues to strengthen the ecosystem by facilitating partnering amongst the partners and creating value by bringing expertise and a clear strategy to enhance partner growth while enabling innovation via a portfolio of activities and programmes.
HBio is a Foundation for Research and Technology - Hellas (FORTH) initiative, facilitated though the PRAXI Network. PRAXI Network, the technology transfer unit of FORTH, has a long-standing experience in supporting SMEs and research organisations during all stages of technology transfer and facilitate actions in order develop successful commercialization pathways.
The grant received will enable HBio to achieve the following strategic goals: